COMMUNIQUÉS West-GlobeNewswire

-
Matchpoint Therapeutics Announces Exclusive Option and License Agreement with Novartis to Develop Oral Inhibitors for Multiple Inflammatory Diseases
24/07/2025 -
Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025
24/07/2025 -
Jeune Announces Positive Results and Significant Aesthetic Improvements from Phase 1 Study of KB304 for Moderate to Severe Wrinkles of the Décolleté
24/07/2025 -
4DMT Announces Presentations at 43rd Annual Scientific Meeting of the American Society of Retina Specialists
24/07/2025 -
BioVie Presented Data Highlighting that Patients Treated with Bezisterim Potentially Experienced an Age Deceleration Advantage Compared to Placebo on 10 Different Biological Clocks at the 2nd World Conference on Aging and Gerontology
24/07/2025 -
Citryll Announces Formation of Scientific Advisory Board
24/07/2025 -
First half of 2025: Solid growth, investments and pipeline progress pave the way for two key launches in H2
24/07/2025 -
Communiqué de presse : Efluelda®, le vaccin haute dose de Sanofi contre la grippe, fait son retour en France pour la saison 2025-2026
24/07/2025 -
Aicuris Enrolled Last Participant in Pivotal Trial with Pritelivir to Treat Refractory Herpes Simplex Infection in Immunocompromised Patients
24/07/2025 -
argenx to Report Half Year 2025 Financial Results and Second Quarter Business Update on July 31, 2025
24/07/2025 -
[Ad hoc announcement pursuant to Art. 53 LR] Roche continues strong momentum with 7% growth (CER) in the first half of 2025
24/07/2025 -
Abivax announces temporary trading halt of its ordinary shares on Euronext Paris
24/07/2025 -
AB Science a obtenu l'autorisation de plusieurs pays européens pour initier l’étude confirmatoire de phase 3 avec le masitinib dans la SLA
24/07/2025 -
AB Science has received approval from several European countries to initiate the confirmatory phase 3 study of masitinib in ALS
24/07/2025 -
Palisade Bio Announces Exercise of Previously Issued Warrants for $3.9 Million
24/07/2025 -
Local Plastic Surgeon in Paramus New Jersey, Dr. Andrew Nouri Educates Patients on Insurance Coverage for Medically Necessary Breast Reduction
24/07/2025 -
TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference
23/07/2025 -
Galapagos Bolster Leadership Team with Seasoned Life Sciences Executives to Accelerate Business Transformation
23/07/2025 -
Cytek Biosciences to Report Second Quarter 2025 Financial Results on August 6, 2025
23/07/2025
Pages